Company
United StatesAzur Pharma, Inc., Philadelphia, PA – FDA Inspections
Inspection records and compliance data for Azur Pharma, Inc. in Philadelphia, Pennsylvania. 3 FDA inspections on record, last inspected September 27, 2011.
Company Profile
This profile covers Azur Pharma, Inc. based in Philadelphia, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected September 10, 2009. Last inspected September 27, 2011.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 27, 2011 | NAI | Human Drugs · Drug Quality Assurance | 748494 |
| April 1, 2011 | NAI | Human Drugs · Bioresearch Monitoring | 716363 |
| September 10, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 610650 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Azur Pharma, Inc.
FEI Number
3007130787
Address
1818 Market St Ste 2350, Philadelphia, Pennsylvania 19103, United States
Country
United States
ID: a0062e24-5101-4d39-8ae4-24c693dff2c8